Enabling biotech to bring novel and sustainable products to the market
Shaping new possibilities for patients through data-driven decisions.
Enable innovative treatments addressing diverse medical needs
Biotech companies focus on fulfilling their mission of bringing innovative medicines to patients with rare and chronic diseases and many other devastating severe illnesses. The conjunction of domain and consulting expertise, data analytics, and technology solutions help companies achieve the following:
- Make strategic growth decisions and develop innovative therapies for niche indications with small patient populations
- Regulatory approvals and compliance for novel treatments
- Informed drug commercialization
- Improved physician targeting, sales, and marketing effectiveness to maximize cost-effectiveness
Our work with biotech companies
Exploit opportunities and navigate challenges, building a foundation for strong growth and sustained value creation
Patient data analytics
Patient data analytics
Axtria worked with a global biotechnology company to develop a patient analytics capability to track the patient journey from the first day of a drug’s launch. We streamlined fragmented patient-level data into a unified data hub for actionable patient-level insights. The effort resulted in 95% patient adherence and reduction in the data-to-insight time.
Account valuation
Account valuation
A biotech company specializing in oncology, collaborated with Axtria to identify the influence of academic and non-academic institutions. The partnership enabled an accurate assessment of value from academic and non-academic institutions. Affiliations were available for 100% of target HCPs and about 90% of the HCP universe.
Launch excellence
Launch excellence
A biotechnology company set to launch its first drug in the oncology market collaborated with Axtria to identify the target audience for the drug, create an optimized salesforce alignment scenario, and develop an incentive compensation payout plan for a successful drug launch. The collaboration resulted in >100% payout to the sales team and demand for the drug exceeding forecast in the first month of drug launch.
Commercial analytics
Commercial analytics
A biotech company partnered with Axtria to create a Axtria DataMAxTM enabled commercial analytics platform for a newly launched vaccine. The effort provided the following benefits: higher quality of data, faster data processing and insights, accurate valuation of key customer segments, sales performance tracking, and visibility into product inventory trends.
Implementation of MDM system
Implementation of MDM system
A biotech company partnered with Axtria to implement a payer/plan MDM system to increase its business intelligence and analytical capabilities. The effort resulted in enhanced payer/plan business intelligence and enabled return on investment (ROI) analytics.